Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sugen (SUGN) -- Ignore unavailable to you. Want to Upgrade?

To: Mike K who wrote (391)	4/8/1999 9:01:00 PM
From: Miljenko Zuanic	Respond to of 550

Sugen has seven posters presentation and one speaker (Gerald McMahon): "Tumor Angiogenesis and Receptor Tyrosine Kinase Inhibitors" , at AACR conference. They may pre-announce this tomorrow in press release, but more likely it will come on Monday or Tuesday. However, AACR (scientific conference) is not as important as ASCO (oncology conference, Atlanta, in May) where Sugen will have several posters presentation on SU101 and SU5416 clinical trials (I hope with some discussion on SU6668, at both conference). Miljenko